BIOMERICA INC Proceeds from Customers
BIOMERICA INC (BMRA) reported Proceeds from Customers of $30.00 thousand for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromCustomers · last filed 2026-04-13
- BIOMERICA INC proceeds from customers for the quarter ending 2026-02-28 was $0.00.
- BIOMERICA INC proceeds from customers for the quarter ending 2025-11-30 was -$24.00K.
- BIOMERICA INC proceeds from customers for the quarter ending 2025-08-31 was $54.00K, a 36.47% decline year-over-year.
- BIOMERICA INC proceeds from customers for the quarter ending 2025-05-31 was $0.00.
- BIOMERICA INC proceeds from customers for fiscal 2025 was $55.00K, a 35.29% decline from fiscal 2024.
- BIOMERICA INC proceeds from customers for fiscal 2024 was $85.00K, a 41.67% increase from fiscal 2023.
- BIOMERICA INC proceeds from customers for fiscal 2023 was $60.00K.
| Period end | Proceeds from Customers 3 month | Proceeds from Customers 6 month | Proceeds from Customers 9 month | Proceeds from Customers 12 month |
|---|---|---|---|---|
| 2026-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | -$24.00K derived: sum of 2 quarters · filed 2026-04-13 | $30.00K 10-Q · filed 2026-04-13 | $30.00K derived: sum of 4 quarters · filed 2026-04-13 |
| 2025-11-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | $30.00K 10-Q · filed 2026-01-14 | $30.00K derived: sum of 3 quarters · filed 2026-01-14 | $0.00 derived: sum of 4 quarters · filed 2026-01-14 |
| 2025-08-31 | $54.00K 10-Q · filed 2025-10-14 | $54.00K derived: sum of 2 quarters · filed 2025-10-14 | $24.00K derived: sum of 3 quarters · filed 2025-10-14 | $24.00K derived: sum of 4 quarters · filed 2025-10-14 |
| 2025-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | -$30.00K derived: sum of 2 quarters · filed 2025-08-29 | -$30.00K derived: sum of 3 quarters · filed 2025-08-29 | $55.00K 10-K · filed 2025-08-29 |
| 2025-02-28 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-14 | -$30.00K derived: sum of 2 quarters · filed 2025-04-14 | $55.00K 10-Q · filed 2025-04-14 | $55.00K derived: sum of 4 quarters · filed 2025-04-14 |
| 2024-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-14 | $85.00K 10-Q · filed 2025-01-14 | $85.00K derived: sum of 3 quarters · filed 2025-01-14 | $110.00K derived: sum of 4 quarters · filed 2025-01-14 |
| 2024-08-31 | $85.00K 10-Q · filed 2024-10-15 | $85.00K derived: sum of 2 quarters · filed 2024-10-15 | $110.00K derived: sum of 3 quarters · filed 2024-10-15 | $110.00K derived: sum of 4 quarters · filed 2024-10-15 |
| 2024-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $25.00K derived: sum of 2 quarters · filed 2024-08-28 | $25.00K derived: sum of 3 quarters · filed 2024-08-28 | $85.00K 10-K · filed 2024-08-28 |
| 2024-02-29 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-12 | $25.00K derived: sum of 2 quarters · filed 2024-04-12 | $85.00K 10-Q · filed 2024-04-12 | $7.00K derived: sum of 4 quarters · filed 2024-04-12 |
| 2023-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | $60.00K 10-Q · filed 2024-01-16 | -$18.00K derived: sum of 3 quarters · filed 2024-01-16 | $71.00K derived: sum of 4 quarters · filed 2024-01-16 |
| 2023-08-31 | $60.00K 10-Q · filed 2023-10-12 | -$18.00K derived: sum of 2 quarters · filed 2023-10-12 | $71.00K derived: sum of 3 quarters · filed 2023-10-12 | -$31.00K derived: sum of 4 quarters · filed 2023-10-12 |
| 2023-05-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | $11.00K derived: sum of 2 quarters · filed 2023-08-25 | -$91.00K derived: sum of 3 quarters · filed 2023-08-25 | $60.00K 10-K · filed 2023-08-25 |
| 2023-02-28 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-14 | -$13.00K derived: sum of 2 quarters · filed 2023-04-14 | $138.00K 10-Q · filed 2023-04-14 | |
| 2022-11-30 | -$102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-13 | $49.00K 10-Q · filed 2023-01-13 | ||
| 2022-08-31 | $151.00K 10-Q · filed 2022-10-13 | |||
| 2022-02-28 | $3.21M 10-Q · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |